Atara Biotherapeutics (ATRA) EBITDA Margin Growth (1y) (2022 - 2026)
Powered by 
Analysis
Atara Biotherapeutics (ATRA) EBITDA Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | 798.00 |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 2.46 Mn |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn | 13,751.00 |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | 2,348.00 |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | -6,012.00 |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | -2.44 Mn |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 375,193.00 |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.35 Bn | 251.87 Mn | -1,560.00 |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 377.00 |
| 10 | Atara Biotherapeutics | 146.20 Mn | 129.64 Mn | 439,000.00 | -76,740.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -76,740.00 |
| Mar 31, 2026 | -69,244.00 |
| Dec 31, 2025 | -12,343.00 |
| Sep 30, 2025 | -4,937.00 |
| Jun 30, 2025 | 8,185.00 |
| Mar 31, 2025 | 15,375.00 |
| Dec 31, 2024 | 137,295.00 |
| Sep 30, 2024 | 320,180.00 |
| Jun 30, 2024 | 739,862.00 |
| Mar 31, 2024 | 600,470.00 |
| Dec 31, 2023 | 2.90 Mn |
| Sep 30, 2023 | -135,816.00 |
| Jun 30, 2023 | -739,998.00 |
| Mar 31, 2023 | -491,274.00 |
| Dec 31, 2022 | -2.92 Mn |
| Sep 30, 2022 | -31,841.00 |
| Jun 30, 2022 | 210,830.00 |
| Mar 31, 2022 | 99,666.00 |